I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...

Prostate cancer kills 35,000 men a year, according to Dr. Roach. But not all cancers are treated the same way.

Do you consider the cancer measurements to be small, thus making the “observation only” protocol correct? — B.A. Dear B.A.: ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa. (HealthDay News) — For patients ...

Investing.com-- Walt Disney Company (NYSE:DIS) presents an attractive risk-reward opportunity at current levels ... Conversely, a bullish case envisions stronger-than-expected ARPU growth and a more ...

Investing.com-- Walt Disney Company (NYSE:DIS) presents an attractive risk-reward opportunity at ... than-expected ARPU growth and a more favorable valuation, pushing shares to $134.

Only 3 of 331 patients had died of prostate cancer at the writing of this article ... the same pattern of clinical progression: initial favorable prognostic factors; rapid rise in PSA which ...

Evidence Rating Level: 1 (Excellent) Study Rundown: Prostate cancer is the most prevalent cancer among men ... testing while the National Comprehensive Cancer Network supports their use in initial ...

No patient has died of prostate cancer or had metastatic disease; 14 (10.4%) have died of other causes. The proportion of patients who would have received treatment using various triggers is ...

The face of cancer in the U.S. is getting younger—and more feminine. Cancer rates for women in the U.S. have risen over the past half-century, particularly among women under age 65 diagnosed ...